Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- HTGMDELISTED
- Price
- -
- Stock movement down
- -0.10 (-23.33%)
- Company name
- HTG Molecular Diagnostics Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Healthcare Equipment & Supplies
- Market cap
- 763.91K
- Ent value
- 8.16M
- Price/Sales
- 0.12
- Price/Book
- 1.61
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -40.37%
- 1 year return (CAGR)
- -97.29%
- 3 year return (CAGR)
- -84.60%
- 5 year return (CAGR)
- -77.63%
- 10 year return (CAGR)
- -
Last updated: 2024-12-17
DIVIDENDS
HTGM does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.12 |
| Price to Book | 1.61 |
| EV to Sales | 1.31 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 2.21M |
| EPS (TTM) | -9.10 |
| FCF per share (TTM) | -7.61 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 6.21M |
| Gross profit (TTM) | 1.35M |
| Operating income (TTM) | -19.59M |
| Net income (TTM) | -20.15M |
| EPS (TTM) | -9.10 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 21.69% |
| Operating margin (TTM) | -315.21% |
| Profit margin (TTM) | -324.28% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 3.00M |
| Net receivables | 1.13M |
| Total current assets | 9.19M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 10.87M |
| Accounts payable | 1.10M |
| Short/Current long term debt | 3.98M |
| Total current liabilities | 6.56M |
| Total liabilities | 10.39M |
| Shareholder's equity | 474.50K |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -16.83M |
| Capital expenditures (TTM) | 20.87K |
| Free cash flow (TTM) | -16.85M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -4246.92% |
| Return on Assets | -185.46% |
| Return on Invested Capital | -499.80% |
| Cash Return on Invested Capital | -417.98% |
STOCK INFORMATION
Stock chart
No data
Stock price data
| Open | 0.34 |
| Daily high | 0.43 |
| Daily low | 0.33 |
| Daily Volume | 5K |
| 1y analyst estimate | 6.00 |
| Beta | 0.99 |
| EPS (TTM) | -9.10 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| HTGM | S&P500 | |
| Current price drop from All-time high | -99.99% | -7.97% |
| Highest price drop | -99.99% | -56.47% |
| Date of highest drop | 3 Jul 2023 | 9 Mar 2009 |
| Avg drop from high | -87.89% | -10.84% |
| Avg time to new high | 417 days | 12 days |
| Max time to new high | 2065 days | 1805 days |
COMPANY DETAILS
Marketcap
763.91K
Marketcap category
Small-cap
Description
HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq Oncology Biomarker Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona. On June 5, 2023, HTG Molecular Diagnostics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Employees
53
Website
Investor relations
-
SEC filings
CEO
John L. Lubniewski
Country
USA
City
Tucson
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner